KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Liabilities (2016 - 2025)

Exact Sciences has reported Total Liabilities over the past 16 years, most recently at $3.5 billion for Q4 2025.

  • Quarterly Total Liabilities fell 1.88% to $3.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 billion through Dec 2025, down 1.88% year-over-year, with the annual reading at $3.5 billion for FY2025, 1.88% down from the prior year.
  • Total Liabilities was $3.5 billion for Q4 2025 at Exact Sciences, up from $3.4 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $3.5 billion in Q3 2024 and troughed at $3.1 billion in Q1 2021.
  • The 5-year median for Total Liabilities is $3.3 billion (2021), against an average of $3.3 billion.
  • Year-over-year, Total Liabilities surged 61.78% in 2021 and then fell 4.39% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $3.3 billion in 2021, then fell by 3.44% to $3.2 billion in 2022, then increased by 4.47% to $3.3 billion in 2023, then grew by 6.01% to $3.5 billion in 2024, then decreased by 1.88% to $3.5 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Total Liabilities are $3.5 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.3 billion (Q2 2025).